Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

33%

Ph phase_1

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution2 total trials

Phase 1Safety & dosage

1(50.0%)

N/ANon-phased studies

1(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Other(1)

Detailed Status

Completed2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (50.0%)

N/A1 (50.0%)

Trials by Status

completed267%

unknown133%

Recent Activity

0 active trials

Showing 3 of 3

completed

Distinct Metastatic Phenotypes Between Early-onset and Late-onset Colorectal Cancer

NCT06040021

unknownphase_1

Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients

NCT04093336

completednot_applicable

Effectiveness of the Multicomponent Therapy in Chronic Pain Through The Use of Smartphones

NCT04509154

Clinical Trials (3)

Showing 3 of 3 trials

NCT06040021

Distinct Metastatic Phenotypes Between Early-onset and Late-onset Colorectal Cancer

Completed

NCT04093336Phase 1

Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients

Unknown

NCT04509154Not Applicable

Effectiveness of the Multicomponent Therapy in Chronic Pain Through The Use of Smartphones

Completed

All 3 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 3